Table 2

Waitlist Outcomes of SL and ML Patients

SL (n = 33,249)ML (n = 679)p Value
Wait time, days
 First listing114 (30–371)332 (146–677)<0.0001
 Second listing126 (35–352)
 Total117 (31–378)470 (227–1,023)<0.0001
HT
 First listing23,345 (70.2)33 (4.9)<0.0001
 Second listing472 (73.1)
 Total23,345 (70.2)505 (74.4)0.0196
Delisting6,047 (18.2)559 (17.7)0.7691
Death while waiting3,857 (12.2)54 (8.1)0.0011
Status at end of first listing<0.0001
 1A11,647 (35.0)49 (7.2)
 1B10,290 (30.9)186 (27.4)
 25,041 (15.2)179 (26.4)
 76,271 (18.8)265 (39.0)
Status at start of second listing<0.0001
 1A134 (19.7)
 1B279 (41.0)
 2206 (30.3)
 760 (8.8)
Status at HT0.1953
 1A11,049 (47.3)253 (50.1)
 1B8,794 (37.7)198 (39.2)
 23,501 (15.0)54 (10.7)
LVAD inserted during first listing2,776 (8.4)38 (5.6)0.0091

Values are n (%) or median (interquartile range).

Significant p values are in bold.

Abbreviations as in Table 1.

  • Comparison between SL and ML cohorts.

  • Pairwise comparison with ML cohort at start of first listing (Table 1).